CAS 329059-55-4

N,N′-(Sulfonyldi-4,1-phenylene)bis[2,2,3,3-tetramethyl-cyclopropanecarboxamide

CAS: 329059-55-4

Fórmula: C₂₈H₃₆N₂O₄S

Pureza: 99.73%

Cor e Forma: Solid

Peso molecular: 496.6614

Ref: IN-DA00C6IN

BRD7116

CAS: 329059-55-4

BRD7116

Pureza: ≥98%

Peso molecular: 496.66g/mol

Ref: 54-BUP14229

BRD7116

CAS: 329059-55-4

BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.

Fórmula: C₂₈H₃₆N₂O₄S

Pureza: 99.69% - 99.91%

Cor e Forma: Solid

Peso molecular: 496.66

Ref: TM-T2353

BRD7116

CAS: 329059-55-4

BRD7116 is an anilide that targets leukemia stem cells and has shown to be effective in the treatment of leukemic patients. BRD7116 has been shown to inhibit proliferation and induce apoptosis in leukemia stem cells, which is a promising therapeutic approach for leukemia. The high-throughput screening assay was used to identify BRD7116 as a potential candidate for the treatment of this disease. This compound inhibits the growth of leukemic stem cells by downregulating proteins essential for cell cycle progression, including CDK2, cyclin D1, and Bcl-2.

Fórmula: C₂₈H₃₆N₂O₄S

Pureza: Min. 95%

Peso molecular: 496.66 g/mol

Ref: 3D-ENA05955